Correlation Between Viridian Therapeutics and Atea Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Atea Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Atea Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Atea Pharmaceuticals, you can compare the effects of market volatilities on Viridian Therapeutics and Atea Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Atea Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Atea Pharmaceuticals.
Diversification Opportunities for Viridian Therapeutics and Atea Pharmaceuticals
-0.45 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Atea is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Atea Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atea Pharmaceuticals and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Atea Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atea Pharmaceuticals has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Atea Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Atea Pharmaceuticals
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.43 times more return on investment than Atea Pharmaceuticals. However, Viridian Therapeutics is 1.43 times more volatile than Atea Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Atea Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest 1,648 in Viridian Therapeutics on August 25, 2024 and sell it today you would earn a total of 314.00 from holding Viridian Therapeutics or generate 19.05% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Atea Pharmaceuticals
Performance |
| Timeline |
| Viridian Therapeutics |
| Atea Pharmaceuticals |
Viridian Therapeutics and Atea Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Atea Pharmaceuticals
The main advantage of trading using opposite Viridian Therapeutics and Atea Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Atea Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea Pharmaceuticals will offset losses from the drop in Atea Pharmaceuticals' long position.| Viridian Therapeutics vs. Eliem Therapeutics | Viridian Therapeutics vs. HCW Biologics | Viridian Therapeutics vs. Scpharmaceuticals | Viridian Therapeutics vs. Milestone Pharmaceuticals |
| Atea Pharmaceuticals vs. Immix Biopharma | Atea Pharmaceuticals vs. Cns Pharmaceuticals | Atea Pharmaceuticals vs. Hepion Pharmaceuticals | Atea Pharmaceuticals vs. Enveric Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |